Initial Clinical Supply Order Sample Clauses
Initial Clinical Supply Order. Syros may submit to TMRC and TMRC shall accept and agree to fulfill, a firm order for clinical supply of Product in substantially the form set forth in Exhibit G.
Initial Clinical Supply Order. Using Initial Compound existing as of the Effective Date, Arena shall manufacture for the quantities and formats of Finished Product and placebo specified in Exhibit D (which Finished Product shall be Initial Product in final form ready for clinical trials) and deliver such Finished Product and placebo to Roivant no later than five (5) months after the Effective Date. Arena will invoice Roivant in accordance with Section 3.11 for (i) Arena’s FTE Costs; and (ii) Arena’s out-of-pocket costs without markup; in each of the foregoing sections (i) and (ii), to the extent incurred after the Effective Date, which amount is due within thirty (30) days of receipt of invoice. *** This portion has been redacted pursuant to a confidential treatment request under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission.
Initial Clinical Supply Order. Between the Original Agreement Effective Date and the Restatement Date, TMRC and Toko filled, using existing inventory held by Toko, an initial order from Syros for clinical supply of API. Following the Restatement Date, the Parties anticipate that TMRC and Toko will not fill further orders from Syros for API and that Syros will instead source API from Third Party supplier(s).